Immunocore Holdings (IMCR) Cash from Investing Activities (2023 - 2026)

Immunocore Holdings has disclosed Cash from Investing Activities across 4 years of filings, most recently posting $4.2 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $4.2 million, down 56.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.8 million (up 93.67% YoY), and the FY2025 annual result was -$16.3 million, up 95.4% from the prior year.
• Cash from Investing Activities came in at $4.2 million for Q1 2026 at Immunocore Holdings, up from -$880000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $9.7 million in Q1 2025 to a low of -$350.3 million in Q2 2024.
• The 4-year median for Cash from Investing Activities is -$828000.0 (2024), against an average of -$28.7 million.
• Across the five-year window, Cash from Investing Activities sank 25013.33% in 2024 and jumped 2356.28% in 2025, its largest moves.
• Immunocore Holdings' Cash from Investing Activities stood at -$817000.0 in 2023, then sank by 333.29% to -$3.5 million in 2024, then soared by 75.14% to -$880000.0 in 2025, then soared by 579.43% to $4.2 million in 2026.
• The last three Cash from Investing Activities figures came in at $4.2 million (Q1 2026), -$880000.0 (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.